Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

EGF Theramed Health

DB:AUHP
Snowflake Description

Overvalued with worrying balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AUHP
DB
CA$684K
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

EGF Theramed Health Corp. operates as a technology company that provides automated biomedical care online services for common health problems. The last earnings update was 28 days ago. More info.


Add to Portfolio Compare Print
  • EGF Theramed Health has significant price volatility in the past 3 months.
AUHP Share Price and Events
7 Day Returns
30.5%
DB:AUHP
4.1%
DE Healthcare Services
7.3%
DE Market
1 Year Returns
-95.5%
DB:AUHP
0.9%
DE Healthcare Services
-17.7%
DE Market
AUHP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
EGF Theramed Health (AUHP) 30.5% -8.7% -53.2% -95.5% -99.9% -
DE Healthcare Services 4.1% -8.3% -18.1% 0.9% 24.9% 85.3%
DE Market 7.3% -17.9% -25.8% -17.7% -25.6% -29%
1 Year Return vs Industry and Market
  • AUHP underperformed the Healthcare Services industry which returned 0.9% over the past year.
  • AUHP underperformed the Market in Germany which returned -17.7% over the past year.
Price Volatility
AUHP
Industry
5yr Volatility vs Market

AUHP Value

 Is EGF Theramed Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for EGF Theramed Health. This is due to cash flow or dividend data being unavailable. The share price is €0.274.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for EGF Theramed Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are EGF Theramed Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:AUHP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in CAD CA$-14.67
CNSX:TMED Share Price ** CNSX (2020-03-30) in CAD CA$0.58
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.1x
Germany Market PE Ratio Median Figure of 400 Publicly-Listed Companies 16.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of EGF Theramed Health.

DB:AUHP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:TMED Share Price ÷ EPS (both in CAD)

= 0.58 ÷ -14.67

-0.04x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EGF Theramed Health is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • EGF Theramed Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does EGF Theramed Health's expected growth come at a high price?
Raw Data
DB:AUHP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.04x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.29x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for EGF Theramed Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on EGF Theramed Health's assets?
Raw Data
DB:AUHP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in CAD CA$0.70
CNSX:TMED Share Price * CNSX (2020-03-30) in CAD CA$0.58
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.88x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.43x
DB:AUHP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:TMED Share Price ÷ Book Value per Share (both in CAD)

= 0.58 ÷ 0.70

0.83x

* Primary Listing of EGF Theramed Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EGF Theramed Health is good value based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess EGF Theramed Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. EGF Theramed Health has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AUHP Future Performance

 How is EGF Theramed Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EGF Theramed Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.6%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is EGF Theramed Health expected to grow at an attractive rate?
  • Unable to compare EGF Theramed Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare EGF Theramed Health's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare EGF Theramed Health's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:AUHP Future Growth Rates Data Sources
Data Point Source Value (per year)
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:AUHP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:AUHP Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-12-31 -1 -14
2019-09-30 -1 -15
2019-06-30 -2 -14
2019-03-31 -2 -1
2018-12-31 -1 -1
2018-09-30 -1 -2
2018-06-30 0 -1
2018-03-31 0 -27
2017-12-31 0 -28
2017-09-30 0 -27
2017-06-30 0 -27
2017-03-31 0 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if EGF Theramed Health is high growth as no earnings estimate data is available.
  • Unable to determine if EGF Theramed Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:AUHP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from EGF Theramed Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:AUHP Past Financials Data
Date (Data in CAD Millions) EPS *
2019-12-31 -14.67
2019-09-30 -12.33
2019-06-30 -18.77
2019-03-31 -2.74
2018-12-31 -1.99
2018-09-30 -3.25
2018-06-30 -3.85
2018-03-31 -144.34
2017-12-31 -202.11
2017-09-30 -239.30
2017-06-30 -291.65
2017-03-31 -14.71

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if EGF Theramed Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. EGF Theramed Health's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. EGF Theramed Health's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess EGF Theramed Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
EGF Theramed Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AUHP Past Performance

  How has EGF Theramed Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare EGF Theramed Health's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • EGF Theramed Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare EGF Theramed Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare EGF Theramed Health's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
EGF Theramed Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from EGF Theramed Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:AUHP Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 -14.31 1.51 -0.22
2019-09-30 -14.54 1.73 -0.22
2019-06-30 -14.40 2.04 -0.22
2019-03-31 -1.40 2.18
2018-12-31 -0.91 1.88
2018-09-30 -1.54 1.47
2018-06-30 -0.94 0.86
2018-03-31 -27.25 0.49
2017-12-31 -27.91 1.14
2017-09-30 -26.77 1.07
2017-06-30 -26.72 1.05
2017-03-31 -1.16 0.92
2016-12-31 -0.33 0.12
2016-09-30 -0.35 0.14
2016-06-30 -0.35 0.14
2016-03-31 0.42 0.05
2015-12-31 0.38 0.05
2015-09-30 0.38 0.05
2015-06-30 0.31 0.10
2015-03-31 -0.15 0.08
2014-12-31 -0.11 0.06
2014-09-30 -0.10 0.05
2014-06-30 -0.05 0.01
2014-03-31 -0.39 0.04
2013-12-31 -0.38 0.04
2013-09-30 -0.37 0.04
2013-06-30 -0.34 0.02
2013-03-31 -0.01 0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if EGF Theramed Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if EGF Theramed Health has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if EGF Theramed Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess EGF Theramed Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
EGF Theramed Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AUHP Health

 How is EGF Theramed Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up EGF Theramed Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • EGF Theramed Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • EGF Theramed Health's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of EGF Theramed Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from EGF Theramed Health Company Filings, last reported 2 months ago.

DB:AUHP Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 0.58 1.48 0.00
2019-09-30 0.68 1.21 0.06
2019-06-30 0.54 1.29 0.13
2019-03-31 13.07 0.90 0.23
2018-12-31 13.69 0.85 1.10
2018-09-30 1.03 0.90 0.90
2018-06-30 -1.69 2.05 0.45
2018-03-31 -1.53 1.25 0.12
2017-12-31 -1.33 1.92 1.17
2017-09-30 -3.50 2.97 0.01
2017-06-30 -3.43 2.98 0.00
2017-03-31 3.43 3.21 0.00
2016-12-31 2.69 3.01 0.01
2016-09-30 2.70 2.66 0.02
2016-06-30 2.56 2.36 0.00
2016-03-31 2.68 1.31 0.01
2015-12-31 2.52 1.05 0.00
2015-09-30 2.55 0.95 0.00
2015-06-30 2.57 0.81 0.01
2015-03-31 2.57 0.68 0.01
2014-12-31 2.63 0.37 0.04
2014-09-30 2.64 0.07 0.01
2014-06-30 1.08 0.98 0.02
2014-03-31 1.10 0.62 0.02
2013-12-31 1.11 0.45 0.01
2013-09-30 0.88 0.38 0.08
2013-06-30 0.88 0.25 0.08
2013-03-31 0.88 0.16 0.01
  • EGF Theramed Health's level of debt (256.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (14.3% vs 256.7% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • EGF Theramed Health has less than a year of cash runway based on current free cash flow.
  • EGF Theramed Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 25.5% each year.
X
Financial health checks
We assess EGF Theramed Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. EGF Theramed Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AUHP Dividends

 What is EGF Theramed Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from EGF Theramed Health dividends.
If you bought €2,000 of EGF Theramed Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate EGF Theramed Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate EGF Theramed Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:AUHP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 1%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as EGF Theramed Health has not reported any payouts.
  • Unable to verify if EGF Theramed Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of EGF Theramed Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as EGF Theramed Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess EGF Theramed Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can EGF Theramed Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. EGF Theramed Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AUHP Management

 What is the CEO of EGF Theramed Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
David Bentil
TENURE AS CEO 0.2 years
CEO Bio

Mr. David Bentil serves as Chief Executive Officer and Director at EGF Theramed Health Corp since January 2020. Mr. Bentil is an Economist by trade. In 2002, he decided to follow his passion by pursuing a career in the car business. In 2002, he joined an independent dealership and began building relationships with high net worth individuals and dealer principals and sales managers, learning to cater to client's needs. He has been successful in building brands, businesses, sales, and raising capital.

CEO Compensation
  • Insufficient data for David to compare compensation growth.
  • Insufficient data for David to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure of the EGF Theramed Health management team in years:

1
Average Tenure
  • The average tenure for the EGF Theramed Health management team is less than 2 years, this suggests a new team.
Management Team

David Bentil

TITLE
CEO & Director
TENURE
0.2 yrs

Chris Brown

TITLE
President
TENURE
1 yrs

Usama Chaudhry

TITLE
CFO & Director

Brendan Purdy

TITLE
Interim Chief Operating Officer of the Medical Blockchain & Data Security Division
TENURE
2.3 yrs
Board of Directors Tenure

Average tenure of the EGF Theramed Health board of directors in years:

0.6
Average Tenure
  • The average tenure for the EGF Theramed Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Sydney, Syd Au

TITLE
Chairman
COMPENSATION
CA$6K

David Bentil

TITLE
CEO & Director
TENURE
0.2 yrs

Usama Chaudhry

TITLE
CFO & Director

Ricardo Rivera-Acevedo

TITLE
Member of Scientific Advisory Board
TENURE
1 yrs

Macarena Cataldo-Hernández

TITLE
Member of Scientific Advisory Board
TENURE
1 yrs

Jay Dhaliwal

TITLE
Director
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess EGF Theramed Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. EGF Theramed Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AUHP News

Simply Wall St News

AUHP Company Info

Description

EGF Theramed Health Corp. operates as a technology company that provides automated biomedical care online services for common health problems. The company provides medical devices, such as Fully Automated Signal Transduction and TULIP, which are used in monitoring schedules, measurement procedures, and conditioning protocols; and Electro-Physiologically Interactive Computing (EPIC) system, as well as physiologically interactive conditioning services. It serves people interested in normalizing blood pressure, blood glucose, and body weight and skin conditions. The company was formerly known as Theramed Health Corporation and changed its name to EGF Theramed Health Corp. in October 2019. EGF Theramed Health Corp. was incorporated in 2011 and is headquartered in Richmond, Canada.

Details
Name: EGF Theramed Health Corp.
AUHP
Exchange: DB
Founded: 2011
CA$438,562
1,179,546
Website: http://theramedhealthcorp.com
Address: EGF Theramed Health Corp.
11280 Twigg Place,
Suite 168,
Richmond,
British Columbia, V6V 0A6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX TMED Common Shares Canadian National Stock Exchange CA CAD 20. Nov 2014
OTCPK EVAH.F Common Shares Pink Sheets LLC US USD 20. Nov 2014
DB AUHP Common Shares Deutsche Boerse AG DE EUR 20. Nov 2014
Number of employees
Current staff
Staff numbers
0
EGF Theramed Health employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/30 23:48
End of day share price update: 2020/03/30 00:00
Last earnings filing: 2020/03/02
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.